Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib

Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib

Background: Development of radioresistance in oral squamous cell carcinoma (OSCC) remains a significant problem in cancer treatment, contributing to the lack of improvement in survival trends in recent decades. Effective strategies to overcome radioresistance are necessary to improve the therapeutic...

Full description

Bibliographic Details
Main Authors: Liwei Lang, Tiffany Lam, Alex Chen, Caleb Jensen, Leslie Duncan, Feng-Chong Kong, Zoya B. Kurago, Chloe Shay, Yong Teng
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cells
Subjects:
radioresistance
akt/s6
capivasertib
nanoparticles
oscc
anticancer
Online Access:https://www.mdpi.com/2073-4409/9/3/533

Internet

https://www.mdpi.com/2073-4409/9/3/533

Similar Items